Cargando…
De Novo Human Cardiac Myocytes for Medical Research: Promises and Challenges
The advent of cellular reprogramming technology has revolutionized biomedical research. De novo human cardiac myocytes can now be obtained from direct reprogramming of somatic cells (such as fibroblasts), from induced pluripotent stem cells (iPSCs, which are reprogrammed from somatic cells), and fro...
Autores principales: | Hamel, Veronique, Cheng, Kang, Liao, Shudan, Lu, Aizhu, Zheng, Yong, Chen, Yawen, Xie, Yucai, Liang, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337883/ https://www.ncbi.nlm.nih.gov/pubmed/28303153 http://dx.doi.org/10.1155/2017/4528941 |
Ejemplares similares
-
Challenging quantal calcium signaling in cardiac myocytes
por: Zahradníková, Alexandra, et al.
Publicado: (2010) -
Redox signaling in cardiac myocytes
por: Santos, Celio X.C., et al.
Publicado: (2011) -
Deciphering ryanodine receptor array operation in cardiac myocytes
por: Xie, Wenjun, et al.
Publicado: (2010) -
The pacemaker current in cardiac Purkinje myocytes
Publicado: (1995) -
Epigenetic regulation of cardiac myocyte differentiation(†)
por: Oyama, Kyohei, et al.
Publicado: (2014)